🇺🇸 FDA
Pipeline program

Ramelteon

01-04-TL-375-044

Phase 2 small_molecule completed

Quick answer

Ramelteon for Sleep Disorders, Circadian Rhythm is a Phase 2 program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda Pharmaceuticals International AG
Indication
Sleep Disorders, Circadian Rhythm
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials